2013
DOI: 10.3892/or.2013.2415
|View full text |Cite
|
Sign up to set email alerts
|

Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas

Abstract: We investigated the prevalence of human papillomavirus (HPV) in a clinical series of 72 patients with head and neck squamous cell carcinoma (HNSCC) using a retrospective and prospective study design. The majority of patients were smokers and/or drinkers and were treated with concomitant chemoradiotherapy (CCR). Furthermore, we assessed the impact of HPV positivity on the response to CCR. Paraffin-embedded samples from HNSCC patients (n=72) were evaluated for the presence of HPV DNA using both GP5+/GP6+ consens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 33 publications
0
19
0
Order By: Relevance
“…DNA was purified using the QIAamp DNA Mini Kit (Qiagen, Benelux, Belgium) according to the manufacturer’s recommended protocol. All DNA extracts were tested for the presence of 18 different HPV genotypes using TaqMan-based real-time PCR, as described previously (Depuydt et al 2006 , 2007 ; Duray et al 2013 ).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…DNA was purified using the QIAamp DNA Mini Kit (Qiagen, Benelux, Belgium) according to the manufacturer’s recommended protocol. All DNA extracts were tested for the presence of 18 different HPV genotypes using TaqMan-based real-time PCR, as described previously (Depuydt et al 2006 , 2007 ; Duray et al 2013 ).…”
Section: Methodsmentioning
confidence: 99%
“…The development of cancers related to HPV infections has significantly complicated the profile of head and neck cancer patients, notably in terms of prognosis and response to treatment. The management of such patients is particularly complex in Europe, where many individuals are heavy smokers and/or drinkers (Duray et al 2012 ; Duray et al 2013 ). Indeed, while non-smoking and nondrinking oropharyngeal patients exhibit an improved response to therapy and a better outcome, tobacco and alcohol consumers with non-oropharyngeal cancers are associated with a heterogeneous prognosis (Ang et al 2010 ; Isayeva et al 2012 ).…”
Section: Introductionmentioning
confidence: 99%
“…DNA was extracted using the QIAamp DNA Mini Kit (Qiagen, Benelux, Belgium) as previously described [20].…”
Section: Dna Extractionmentioning
confidence: 99%
“…Detection of HPV by polymerase chain reaction (PCR) amplification HPV DNA detection was performed using PCR with GP5+/GP6+ primers (synthesized by Eurogentec, Liege, Belgium) that amplify a consensus region located within the L1 region of the HPV genome as previously described [20].…”
Section: Dna Extractionmentioning
confidence: 99%
See 1 more Smart Citation